New way to tackle disease-causing proteins wins €20k in innovation competition
A team of international students and postdocs, including an Imperial researcher, have won the Merck Innovation Cup for their new drug innovation.
Bacteria ‘factories’ used to discover potential new malaria drugs
Researchers have engineered bacteria to produce new versions of a potential antibiotic molecule, some with potent antimalarial properties.
Feature
Four ways Imperial is leading the fight against Parkinson’s
In the lead up to World Parkinson’s Day on 11 April, we reflect on how Imperial scientists are advancing research to tackle the condition.
New COVID-19 project will use the power of smartphones to search for treatments
Imperial researchers will look for potential new treatments for COVID-19 using the computing power of people’s smartphones.
14
Imperial physicist and chemist honoured in premier young scientist awards
Professor Claudia de Rham and Professor Matthew Fuchter receive accolades in the annual Blavatnik Awards for Young Scientists.
Cell ‘hands’ to unlock doors in health research, drug design, and bioengineering
A previously overlooked cell membrane protein could help to further cancer research, drug design, and bioengineering, according to new research.
Researchers identify a new way to target treatment-resistant cancers
An international team of researchers has found a different way cancer becomes resistant to chemotherapy, suggesting a new target for drugs.
Cholesterol-cutting gene silencing treatment shows lasting effects
Twice-yearly injections of a cholesterol-cutting medication could offer patients lasting reduction in cholesterol, cutting risk of heart attacks.
Developing a vaccine revolution: Imperial experts take on global epidemics
Imperial’s work to develop smarter, more effective and flexible vaccines was showcased to a global audience from government, industry and charities.
Smart design could prevent drug resistance in new malaria treatments
Researchers have overcome malaria parasites’ resistance to potential new drugs by studying how it evolves.
